Cargando…
PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis
OBJECTIVE: This study conducted a comprehensive analysis of the members of the PTPN family and emphasized the key role of PTPN2 as a potential therapeutic target and diagnostic biomarker in improving the survival rate of PAAD. METHOD: Oncomine was used to analyze the pan-cancer expression of the PTP...
Autores principales: | Kuang, Wenbin, Wang, Xiao, Ding, Jiayu, Li, Jiaxing, Ji, Minghui, Chen, Weijiao, Wang, Liping, Yang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829144/ https://www.ncbi.nlm.nih.gov/pubmed/35154122 http://dx.doi.org/10.3389/fimmu.2022.805311 |
Ejemplares similares
-
Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma
por: Wang, Xiao, et al.
Publicado: (2022) -
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
por: Yuan, Kai, et al.
Publicado: (2022) -
High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
por: Wang, Yu, et al.
Publicado: (2018) -
Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer
por: Ding, Jiayu, et al.
Publicado: (2022) -
Clinicopathological significance of PTPN12 expression in human breast cancer
por: Yuan, Xunyi, et al.
Publicado: (2012)